Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease()

Detalles Bibliográficos
Autores principales: González-Castro, A., Cuenca Fito, E., Fernandez, A., Escudero Acha, P., Rodríguez Borregán, J.C., Peñasco, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier España, S.L.U. 2022
Materias:
Scientific Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866085/
https://www.ncbi.nlm.nih.gov/pubmed/35256321
http://dx.doi.org/10.1016/j.medine.2022.02.013
_version_ 1784655759884156928
author González-Castro, A.
Cuenca Fito, E.
Fernandez, A.
Escudero Acha, P.
Rodríguez Borregán, J.C.
Peñasco, Y.
author_facet González-Castro, A.
Cuenca Fito, E.
Fernandez, A.
Escudero Acha, P.
Rodríguez Borregán, J.C.
Peñasco, Y.
author_sort González-Castro, A.
collection PubMed
description
format Online
Article
Text
id pubmed-8866085
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-88660852022-02-24 Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease() González-Castro, A. Cuenca Fito, E. Fernandez, A. Escudero Acha, P. Rodríguez Borregán, J.C. Peñasco, Y. Med Intensiva (Engl Ed) Scientific Letter Published by Elsevier España, S.L.U. 2022-05 2022-02-24 /pmc/articles/PMC8866085/ /pubmed/35256321 http://dx.doi.org/10.1016/j.medine.2022.02.013 Text en © 2022 Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Scientific Letter
González-Castro, A.
Cuenca Fito, E.
Fernandez, A.
Escudero Acha, P.
Rodríguez Borregán, J.C.
Peñasco, Y.
Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease()
title Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease()
title_full Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease()
title_fullStr Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease()
title_full_unstemmed Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease()
title_short Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease()
title_sort combined therapy of tocilizumab and corticosteroids in severe sars-cov-2 disease()
topic Scientific Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866085/
https://www.ncbi.nlm.nih.gov/pubmed/35256321
http://dx.doi.org/10.1016/j.medine.2022.02.013
work_keys_str_mv AT gonzalezcastroa combinedtherapyoftocilizumabandcorticosteroidsinseveresarscov2disease
AT cuencafitoe combinedtherapyoftocilizumabandcorticosteroidsinseveresarscov2disease
AT fernandeza combinedtherapyoftocilizumabandcorticosteroidsinseveresarscov2disease
AT escuderoachap combinedtherapyoftocilizumabandcorticosteroidsinseveresarscov2disease
AT rodriguezborreganjc combinedtherapyoftocilizumabandcorticosteroidsinseveresarscov2disease
AT penascoy combinedtherapyoftocilizumabandcorticosteroidsinseveresarscov2disease

Ejemplares similares